Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Annexon, Inc. - common stock
(NQ:
ANNX
)
5.050
-0.180 (-3.44%)
Streaming Delayed Price
Updated: 11:02 AM EST, Dec 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
205,299
Open
5.220
Bid (Size)
5.040 (8)
Ask (Size)
5.060 (2)
Prev. Close
5.230
Today's Range
5.000 - 5.220
52wk Range
3.860 - 8.400
Shares Outstanding
47,722,995
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)
December 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Performance
YTD
+4.34%
+4.34%
1 Month
-1.75%
-1.75%
3 Month
-24.06%
-24.06%
6 Month
+5.87%
+5.87%
1 Year
+14.51%
+14.51%
More News
Read More
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting
December 05, 2024
From
Annexon Biosciences
Via
GlobeNewswire
ANNX Stock Earnings: Annexon Meets EPS for Q2 2024
August 12, 2024
Via
InvestorPlace
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
November 14, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Present at the Jefferies London Healthcare Conference
November 13, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
October 21, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
October 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
October 15, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
September 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in GA at the Retina Society 57th Annual Meeting and 24th Euretina Congress
September 09, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Expands Senior Leadership in Commercial, Medical Affairs and Health Economics to Advance Global Late-Stage Neuroinflammatory-Targeted Portfolio
September 03, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Participate in Upcoming September Investor Conferences
August 29, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Second Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
August 12, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy
August 05, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
July 12, 2024
Via
Benzinga
Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting
July 11, 2024
From
Annexon Biosciences
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting
June 25, 2024
From
Annexon Biosciences
Via
GlobeNewswire
7 Top Stocks Under $10: June 2024 Edition
June 24, 2024
Via
InvestorPlace
Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting
June 18, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
June 17, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.